当前位置:药药网 / 数据中心 / PubMed 中的摘要说明,变体和药物之间的可能关系
利伐沙班
文献标题
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
杂志
Pharmacogenomics and Personalized Medicine
句子
In situations of double or triple antithrombotic rivaroxaban and clopidogrel therapy among patients with AF and ACS, the genetic factors associated with bleeding complications risk ( CYP2C19*17 rs12248560 ) may prove to be clinically relevant.